The Petrie-Flom Center celebrated its first decade and kicked off the next by looking at the future of health law and policy! The Center brought together Petrie-Flom and other prominent Harvard Law School alumni to discuss major trends, developments, and open questions in the fields of health law policy, biotechnology, and bioethics. We heard about…
Join co-editors Holly Fernandez Lynch (Petrie-Flom Executive Director) and I. Glenn Cohen (Petrie-Flom Faculty Director) and contributor Lewis Grossman (American University) for a discussion of FDA in the 21st Century: The Challenges of Regulating Drugs and New Technologies (Columbia University Press, 2015). This volume stems from the Center’s 2013 annual conference, which brought together leading…
Presentation Download the Presentation (two files): “Does Medical Malpractice Law Improve Health Care Quality?” and Appendix About the Presenter In Spring 2016, Michael Frakes was an Associate Professor of Law at Northwestern Law. He was also a Faculty Research Fellow at the National Bureau of Economic Research and a Faculty Fellow at Northwestern’s Institute for…
Some subjects who participate in trials of novel therapies mistakenly believe that the trial is designed to maximize benefit to the individual subjects — thus laboring under the Therapeutic Misconception. Patients with ALS have a uniformly fatal disease, and some worry that ALS patients are even more prone to the therapeutic misconception. Our speakers will…
It is often said that health care has moved from paternalism, in the form of “doctor knows best,” to consumerism, in which patients expect to be able to obtain treatment consistent with their values and preferences. This presentation explored some of the limits to consumerism in health care, with a particular focus on circumstances where…
Harvard Negotiation Law Review Presents its 21st Annual Symposium Agenda Overview Keynote Address: Dr. Leonard Marcus, Founding Director of the Program for Health Care Negotiation and Conflict Resolution at the Harvard T.H. Chan School of Public Health PANEL 1: Balancing Incentives for Innovation with Affordable Drug Prices: Understanding Interests PANEL 2: Mergers & Acquisitions: Unique…
About the Speaker Tom Shakespeare is Senior Lecturer at Norwich Medical School, the University of East Anglia. From his website: My primary research interests are in disability studies, medical sociology, and in social and ethical aspects of genetics. I have had a long involvement with the disabled people’s movement in UK and internationally. In the…
Presentation About the Presenter Tom Shakespeare is Senior Lecturer at Norwich Medical School, the University of East Anglia. From his website: My primary research interests are in disability studies, medical sociology, and in social and ethical aspects of genetics. I have had a long involvement with the disabled people’s movement in UK and internationally. In…
The 2010 passage of the Biologics Price Competition and Innovation Act was intended to create a pathway for the approval of biosimilar drugs, to bring to market less expensive versions of innovators’ biologic therapeutics in the same way the Hatch-Waxman Act has worked so well for FDA approval of generic small-molecule drugs. But the Act…
Amanda Pustilnik, JD and Maureen Strafford MD discussed fetal pain, including advances in neuroscience and treatment and their implications for the law. This event was free and open to the public. Presenters Amanda Pustilnik, JD, served as the inaugural Senior Fellow in Law and Applied Neuroscience as part of the Project on Law and Applied Neuroscience, a collaboration between…
